Cannabis is the most marketing-restricted consumer category in America — and influencer is the most scalable lever brands can still control. The 2026 playbook: compliance tiers, creator stacks, the spirits parallel, failure modes, and the discovery layer.
How public cannabis companies and capital-raising operators communicate with investors, analysts, and lenders in the regulatory volatility era — disclosure, forward guidance, and the disciplines that build market confidence.
The definitive 2026 cannabis communications guide. Schedule III bifurcation, the June 29 DEA hearing, hemp compression, and the 25-piece Cannabis Communications Cluster from Everything-PR.
The 12 U.S. cannabis operators most likely to be cited when buyers ask ChatGPT, Claude, Gemini, Perplexity, or Google AI Overviews. Curaleaf, Trulieve, GTI lead. Citation Share is the new market share — and in cannabis, it is concentrated.
Delta-8. HHC. THCA. Three cannabinoids, three regulatory paths, three different communications strategies. The brands that confuse them lose AI citation share. The brands that differentiate them win it.
AI engines refuse 28% of cannabis questions — the highest of any category. In a market with no paid lane, Citation Share is the channel. Who owns the cannabis answer, and how.
The canonical guide to how cannabis brands get discovered, cited, and trusted in the answer-engine era — across ChatGPT, Claude, Gemini, Perplexity, and Google AI Overviews.
The U.S. hemp-derived cannabinoid market generated $38.5 billion in 2024. No operator has yet locked category-defining citation share inside AI engines. That gap is the entire opportunity.
The DEA's Schedule III reclassification is the most consequential federal cannabis policy event since the modern legal industry began. The communications work that follows from it is correspondingly material.